---  
layout: startup_page  
title: "Aardvark Therapeutics"  
id: "aardvarktherapeutics.com"  
permalink: "/aardvarktherapeuticsaardvarktherapeutics.com05092024/"  
website: "https://www.aardvarktherapeutics.com/"  
funding_round: "Series C"  
funding_amount: "$85M"  
investors: "Decheng Capital, Cormorant Asset Management, Surveyor Capital, SymBiosis, Tetragon Financial Group, Walleye Capital, Laurion Capital Management, LG Technology Ventures, Cantor Ventures, Silver Arc Private Capital, The Prader-Willi Syndrome Association â€“ USA, Vickers Venture Partners, Foundation for Prader-Willi Research"  
about: "Aardvark Therapeutics is a clinical-stage biopharmaceutical company developing novel, small-molecule therapeutics to activate innate homeostatic pathways for treating metabolic diseases and inflammation. Their lead compound, ARD-101, is an oral drug targeting bitter taste receptors to reduce hunger. This drug shows promise in treating Prader-Willi Syndrome and obesity."  
markets: "Biotechnology, Pharmaceuticals, Therapeutics"  
hq: "San Diego, California, United States"  
founded_year: ""  
linkedin: "https://www.linkedin.com/company/aardvark-therapeutics"  
twitter: ""  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/aardvark-therapeutics"  
pitchbook: "https://pitchbook.com/profiles/company/267589-81"  

date_display: "09-May-2024"  
date: "2024-05-09"

# SEO Optimization  
meta_title: "Aardvark Therapeutics - Series C Funding ($85M)"  
meta_description: "Aardvark Therapeutics, Aardvark Therapeutics is a clinical-stage biopharmaceutical company developing novel, small-molecule therapeutics to activate innate homeostatic pathw..."  
meta_keywords: "Aardvark Therapeutics, Biotechnology, Pharmaceuticals, Therapeutics, Series C funding"  
canonical_url: "https://startup.projectstartups.com/aardvarktherapeuticsaardvarktherapeutics.com05092024/"  
---